Active, not recruitingPhase 2NCT04879563

Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project

Studying Toxic dermatosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Region Örebro County
Principal Investigator
Paris Kosmidis
CareAcross
Intervention
ASCAPE-based follow-up strategy(other)
Enrollment
500 enrolled
Eligibility
18 years · All sexes
Timeline
2021 – 2025

Study locations (5)

Collaborators

UBITECH · ATOS · Siemens Corporation, Corporate Technology · Intrasoft · University of Patras · FORTH - Foundation for Research and Technology Hellas · Sphynx Technology Solutions AG · Faculty of Sciences, University of Novi Sad, Serbia · DFKI - German Research Center for Artificial Intelligence · CareAcross · National and Kapodistrian University of Athens · Fundacio Clinic Barcelona · Arthur's Legal · Fundacion iSYS

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04879563 on ClinicalTrials.gov

Other trials for Toxic dermatosis

Additional recruiting or active studies for the same condition.

See all trials for Toxic dermatosis →

← Back to all trials